Hubhopper - Robust and Easy to Create and Distribute Podcasts

Repurposing rheumatology drugs for COVID-19: JAK inhibitors

About

Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.

Medicine Matters rheumatology

January 25, 2021

Miscellaneous

Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.